Kobayashi Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kobayashi Pharmaceutical Co Ltd with three other
companies in this sector in Japan:
Santen Pharmaceutical Company Limited
sales of 195.29 billion Japanese Yen [US$1.76 billion]
of which 99%
was Pharmaceutical Products),
Ono Pharmaceutical Co Ltd
(160.28 billion Japanese Yen [US$1.44 billion]
of which 31%
was Metabolic Medicine And Vitamin compound), and
Nichi-Iko Pharmaceutical Company Limited
(143.51 billion Japanese Yen [US$1.29 billion]
of which 100%
was Ethical Pharmaceutical).
Kobayashi Pharmaceutical Co Ltd reported sales of ¥160.07 billion (US$1.44 billion)
December of 2016.
increase of 24.7%
versus 2015, when the company's sales were ¥128.34 billion.
This was the third consecutive year of growth at Kobayashi Pharmaceutical Co Ltd.